Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial - Brasky, Theodore M.; Darke, Amy K.; Song, Xiaoling; Tangen, Catherine M.; Goodman, Phyllis J.; Thompson, Ian M.; Meyskens, Frank L.; Goodman, Gary E.; Minasian, Lori M.; Parnes, Howard L.; Klein, Eric A.; Kristal, Alan R. (JNCI : Journal of the National Cancer Institute, 2013)
Keywords: Age; Aged; Case-Control Studies; Dietary Supplements - adverse effects; Fatty acids; Fatty Acids, Omega-3 - adverse effects; Fatty Acids, Omega-3 - blood; Fatty Acids, Omega-6 - blood; Humans; Incidence; Male; Medical research; Mens health; Middle Aged; Neoplasm Grading; Odds Ratio; Phospholipids; Proportional Hazards Models; Prospective Studies; Prostate cancer; Prostatic Neoplasms - blood; Prostatic Neoplasms - diagnosis; Prostatic Neoplasms - epidemiology; Prostatic Neoplasms - pathology; Prostatic Neoplasms - prevention & control; Risk Assessment; Risk Factors; Selenium - administration & dosage; Treatment Failure; United States - epidemiology; Vitamin E - administration & dosage; United States